|
⚲
|
| Keyboard |
| Savitz Ryan
✚
|
|
|---|---|
| CIK # | 0001992324 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001992324] | |
| 4 | [0001992324] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dianthus Therapeutics Inc /DE/ | |
| Savitz Ryan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2026-02-03 | Grant | 150,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Common Stock
|
2025-12-04 | Sell | 20,000 | $45.18 | 903,600 |
|
Dianthus Therapeutics Inc /DE/ DNTH
Common Stock
|
2025-12-04 | Option exercise | 20,000 | $8.44 | 168,800 |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2025-12-04 | Option exercise | 20,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 150,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 100,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2024-01-24 | Grant | 120,000 | $0.00 |